PharmiWeb.com - Global Pharma News & Resources
05-May-2022

Global Thrombectomy Systems (Catheters) Medical Device Pipeline Market Landscape Report 2021: Stage of Development, Segment, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Thrombectomy Systems (Catheters) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.


The report provides comprehensive information about the Thrombectomy Systems (Catheters) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Thrombectomy system involves the application of negative pressure for the removal of thrombi which is sometimes accompanied with thrombolytic drugs.

Scope

  • Extensive coverage of the Thrombectomy Systems (Catheters) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Thrombectomy Systems (Catheters) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Thrombectomy Systems (Catheters) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Thrombectomy Systems (Catheters) Overview

3 Products under Development

3.1 Thrombectomy Systems (Catheters) - Pipeline Products by Stage of Development

3.2 Thrombectomy Systems (Catheters) - Pipeline Products by Territory

3.3 Thrombectomy Systems (Catheters) - Pipeline Products by Regulatory Path

3.4 Thrombectomy Systems (Catheters) - Pipeline Products by Estimated Approval Date

3.5 Thrombectomy Systems (Catheters) - Ongoing Clinical Trials

4 Thrombectomy Systems (Catheters) - Pipeline Products under Development by Companies

4.1 Thrombectomy Systems (Catheters) Companies - Pipeline Products by Stage of Development

4.2 Thrombectomy Systems (Catheters) - Pipeline Products by Stage of Development

5 Thrombectomy Systems (Catheters) Companies and Product Overview

5.1 AngioDynamics Inc Company Overview

5.2 Boston Scientific Corp Company Overview

5.3 Caeli Vascular LLC Company Overview

5.4 Capture Vascular Inc Company Overview

5.5 Inari Medical Inc Company Overview

5.6 Merit Medical Systems Inc Company Overview

5.7 MicroPort Endovascular (Shanghai) Co., Ltd. Company Overview

5.8 NexGen Medical Systems Inc Company Overview

5.9 Suzhou Tianhong Shengjie Medical Co Ltd Company Overview

5.10 TransMed7 LLC Company Overview

5.11 University of California Los Angeles Company Overview

5.12 University of Toledo Company Overview

5.13 University of Wolverhampton Company Overview

5.14 Vetex Medical Ltd Company Overview

5.15 WaveClear Inc Company Overview

5.16 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

6 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/2cofrd


Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 05-May-2022